The family of former president and army chief General (retired) Pervez Musharraf has said in the latest statement that they need to consider significant medical, legal and security challenges before any decision about the former president’s return to Pakistan.
The family, on social media, stated that official along with unofficial communications had promised facilitation about Musharraf’s return home. However, the major concern raised by the family in shifting the former president to Pakistan is regarding uninterrupted supply and administration of the drug ‘Daratumumab’ that is needed alongside associated treatment.
Pervez Musharraf, who is suffering from the disease ‘Amyloidosis’ has been in a critical condition and admitted to the intensive care unit (ICU) of Dubai Hospital.
Musharraf had left the country for Dubai in 2016. The illness of the former premier had first come to light in 2018. Amyloidosis is a disease in which an abnormal protein namely amyloid builds in body organs and tissues causing them to malfunction.
Earlier, former prime minister and Pakistan Muslim League-Nawaz’s (PML-N) leader Nawaz Sharif who had always spoken against Musharraf had also stated on social media that he had no personal enmity with Musharraf and government should facilitate if he wanted to return to Pakistan.
Director general of Inter-Services Public Relations (DG ISPR) said in a statement to the media that Musharraf’s return was the decision of his family and doctors to make; adding, “The stance of the institution and its leadership is that he should come back.”
